ADR Institute of Alberta

American Rare Earths Appoints New Chairman

Retrieved on:

Friday, November 17, 2023

Annual general meeting, Annual, NYSE, Harvard Business School, TDW, Element, ASX, ARR, MBA, Retirement, ADR Institute of Alberta, Rare-earth element, Management

Mr. Kenneth ‘Ken’ Traub, who joined the Board on August 18, 2023, has become Chairman effective immediately after Mr. O'Connor's retirement.

Key Points:

Mr. Kenneth ‘Ken’ Traub, who joined the Board on August 18, 2023, has become Chairman effective immediately after Mr. O'Connor's retirement.
“It has been a privilege to have served American Rare Earths from its formative years to where it is today.
“American Rare Earths has a critically important mission.
American Rare Earths owns some of the largest reserves of rare earths in North America and we intend to pursue the most effective strategies to meet this critical need while building sustainable value for our shareholders.”
This market announcement has been authorized for release by the Board of American Rare Earths Limited.

BARCLAYS SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Barclays To Contact Him Directly To Discuss Their Options

Retrieved on:

Tuesday, December 5, 2023

FCA, NYSE, Advertising, LLP, Woman, Multimedia, BCS, ADR Institute of Alberta, ADR, Court, OTC, News, Cryptocurrency, Barclays

NEW YORK, Dec. 5, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Barclays PLC ("Barclays" or the "Company") (NYSE: BCS, OTC: BCLYF) and reminds investors of the January 2, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Key Points:

If you suffered losses exceeding $100,000 investing in Barclays securities between July 22, 2019 and October 12, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext.
Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
On this news, Barclays' ADRs fell $0.39 per ADR, or 4.98% to close at $7.43 per ADR on October 12, 2023, damaging investors.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Barclay's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

BARCLAYS INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Barclays To Contact Him Directly To Discuss Their Options

Retrieved on:

Thursday, November 30, 2023

FCA, NYSE, Advertising, LLP, Woman, Multimedia, BCS, ADR Institute of Alberta, ADR, Court, OTC, News, Cryptocurrency, Barclays

NEW YORK, Nov. 30, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Barclays PLC ("Barclays" or the "Company") (NYSE: BCS, OTC: BCLYF) and reminds investors of the January 2, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Key Points:

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
When the true details entered the market, the lawsuit claims that investors suffered damages.
On this news, Barclays' ADRs fell $0.39 per ADR, or 4.98% to close at $7.43 per ADR on October 12, 2023, damaging investors.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Barclay's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

BARCLAYS DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Barclays To Contact Him Directly To Discuss Their Options

Retrieved on:

Saturday, November 25, 2023

FCA, NYSE, Advertising, LLP, Woman, Multimedia, BCS, ADR Institute of Alberta, ADR, Court, OTC, News, Cryptocurrency, Barclays

NEW YORK, Nov. 25, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Barclays PLC ("Barclays" or the "Company") (NYSE: BCS, OTC: BCLYF) and reminds investors of the January 2, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Key Points:

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
When the true details entered the market, the lawsuit claims that investors suffered damages.
On this news, Barclays' ADRs fell $0.39 per ADR, or 4.98% to close at $7.43 per ADR on October 12, 2023, damaging investors.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Barclay's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

BARCLAYS SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Barclays To Contact Him Directly To Discuss Their Options

Retrieved on:

Saturday, November 18, 2023

FCA, NYSE, Advertising, LLP, Woman, Multimedia, BCS, ADR Institute of Alberta, ADR, Court, OTC, News, Cryptocurrency, Barclays

NEW YORK, Nov. 18, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Barclays PLC ("Barclays" or the "Company") (NYSE: BCS, OTC: BCLYF) and reminds investors of the January 2, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Key Points:

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
When the true details entered the market, the lawsuit claims that investors suffered damages.
On this news, Barclays' ADRs fell $0.39 per ADR, or 4.98% to close at $7.43 per ADR on October 12, 2023, damaging investors.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Barclay's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

BARCLAYS INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Barclays To Contact Him Directly To Discuss Their Options

Retrieved on:

Monday, November 13, 2023

FCA, NYSE, Advertising, LLP, Woman, Multimedia, BCS, ADR Institute of Alberta, ADR, Court, OTC, News, Cryptocurrency, Barclays

NEW YORK, Nov. 13, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Barclays PLC ("Barclays" or the "Company") (NYSE: BCS, OTC: BCLYF) and reminds investors of the January 2, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Key Points:

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
When the true details entered the market, the lawsuit claims that investors suffered damages.
On this news, Barclays' ADRs fell $0.39 per ADR, or 4.98% to close at $7.43 per ADR on October 12, 2023, damaging investors.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Barclay's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

BENECARD PBF WINS PBMI 2023 EXCELLENCE AWARD FOR CLINICAL INNOVATION

Retrieved on:

Friday, November 10, 2023

Well, Senior, Disulfiram-like drug, Doctor of Pharmacy, Patient, Pharmacy, Metabolism, Emergency Care Coordination Center, Science, Death, Communication, Disability, ADR Institute of Alberta, PBM, Education, International Design Excellence Awards, Pharmaceutical industry, Nursing

BONITA SPRINGS, Fla., Nov. 10, 2023 /PRNewswire/ -- BeneCard PBF, a truly transparent PBM offering a pure pass-through business model, has been awarded the 2023 Excellence Award for Clinical Innovation by the Pharmacy Benefit Management Institute (PBMI) for their b Well Ahead model.

Key Points:

BONITA SPRINGS, Fla., Nov. 10, 2023 /PRNewswire/ -- BeneCard PBF, a truly transparent PBM offering a pure pass-through business model, has been awarded the 2023 Excellence Award for Clinical Innovation by the Pharmacy Benefit Management Institute (PBMI) for their b Well Ahead model.
The innovative b Well Ahead offering, which encompasses the 2020 Excellence Award winning Care Coordination program, now includes proprietary machine learning technology.
"This product offering is the first of its kind within the PBM space," says Michael Perry, President, BeneCard PBF.
All submissions are reviewed and scored by the PBMI Excellence Award evaluation panel.

BARCLAYS SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Barclays To Contact Him Directly To Discuss Their Options

Retrieved on:

Wednesday, November 8, 2023

NYSE, BCS, ADR, OTC, News, Court, Advertising, Multimedia, Woman, LLP, ADR Institute of Alberta, FCA, Cryptocurrency, Barclays

NEW YORK, Nov. 8, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Barclays PLC ("Barclays" or the "Company") (NYSE: BCS, OTC: BCLYF) and reminds investors of the January 2, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Key Points:

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
When the true details entered the market, the lawsuit claims that investors suffered damages.
On this news, Barclays' ADRs fell $0.39 per ADR, or 4.98% to close at $7.43 per ADR on October 12, 2023, damaging investors.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Barclay's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

BARCLAYS SHAREHOLDER ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Barclays To Contact Him Directly To Discuss Their Options

Retrieved on:

Friday, November 3, 2023

NYSE, BCS, ADR, OTC, News, Court, Advertising, Multimedia, Woman, LLP, ADR Institute of Alberta, FCA, Cryptocurrency, Barclays

NEW YORK, Nov. 3, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Barclays PLC ("Barclays" or the "Company") (NYSE: BCS, OTC: BCLYF) and reminds investors of the January 2, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Key Points:

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
When the true details entered the market, the lawsuit claims that investors suffered damages.
On this news, Barclays' ADRs fell $0.39 per ADR, or 4.98% to close at $7.43 per ADR on October 12, 2023, damaging investors.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Barclay's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

SYLA Reports First-Half 2023 Financial and Operational Results

Retrieved on:

Tuesday, October 17, 2023

TOKYO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- SYLA Technologies Co., Ltd. (NASDAQ: SYT) (“SYLA” or “the Company”), operator of the largest membership real estate crowd-funding platform in Japan, Rimawari-kun, reported its interim financial results for the six months ended June 30, 2023.

Key Points:

Appointed Hajime Sugino as Head of SYLA USA to oversee the expansion of SYLA’s US-based operations and international investor communication efforts.
(*SYLA Biotech Co., Ltd. started a containerized data center business during 2023, in which SYLA Biotech provides a one-stop service covering construction, installation, operation, and maintenance of the data centers.
As of June 30, 2023, SYLA Technologies Co., Ltd. had ¥3,565,988 thousand ($24.7 million) in cash and cash equivalents.
Total net assets increased to ¥9,445,397 thousand ($65.4 million) as of June 30, 2023 from ¥6,566,690 thousand ($45.5 million) as of December 31, 2022.